focus -WSS

focus

author：knowledge 2025-10-06 07:54:46 - browse：9765

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Wikipedia

leisure time

WSS

Group behind ProMed defends move to subscription

Covid silver lining: Unprecedented look at human immune system

Pancreatic cancer is often deadly, but new discoveries are raising hope

Insurer loopholes limit power of law against surprise medical bills

CDC recommends RSV monoclonal antibody for infants

H.R. 3 is the wrong path to lower drug costs

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Activists slam private health insurers over coverage restrictions

How I helped Pfizer think through the ethics of Viagra

Drug repurposing or repositioning? The language matters

Covid silver lining: Unprecedented look at human immune system

Sports medicine is finally prioritizing gender equality

Covid silver lining: Unprecedented look at human immune system

In age of alternative facts, a scholarly course on calling out crap

H.R. 3 is the wrong path to lower drug costs

Cancer drug shortages should be causing more outrage

Republican states more likely to report Covid vaccine side effects

Wikipedia

Four alarming medical procedures we’re glad history forgot

FDA approves Sage Therapeutics’ rapid

People with mental disorders often marry others with same

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Physicians aren't 'burning out.' They're suffering from moral injury

Harvard scientists, with Google, unveil the most detailed brain map ever

leisure time

Wikipedia

leisure time

hotspot